Navigation Links
UC Davis researchers identify a cellular pathway that makes prostate cancer fatal
Date:11/28/2007

(SACRAMENTO, Calif.) Expanding evidence that tiny strands of RNA called microRNAs play big roles in the progress of some cancers, UC Davis researchers have identified one that helps jump start prostate cancer cell growth midway through the disease process, eventually causing it to become fatal. The discovery is an important link to finding new treatments targeting this cellular function and reducing cancer deaths among American men.

A number of cancer researchers are interested in microRNAs and how they are involved in diseases like leukemia, said Ralph deVere White, director of the UC Davis Cancer Center, professor of urology and senior author on the study. But this is the first research to specifically look at the functional effects of microRNAs on the progression of prostate cancer.

Relatively new discoveries in genetic research, microRNAs are small, single strands of RNA that regulate gene expression processes between larger strands of RNA. Working with 19 samples from the cancer centers repository of prostate cancer cells, deVere White and his team used high-resolution analysis techniques to identify microRNAs that were differentially expressed. Of five that were distinct, one miR-125b caught their attention because of its presence at high levels in both androgen-dependent and androgen-independent prostate cancer cells. Androgens, such as testosterone, are known to promote tumor growth. While androgen suppression treatments slow the progress of prostate cancer, they do not cure it.

One of the most confounding things about prostate cancer is that after a period of success with androgen suppression therapy, the cancer starts to thrive again, deVere White explained. Thats when the disease becomes fatal. This particular microRNA supports the ability of prostate cancer cells to exist and grow in its androgen-independent state. And we currently have no effective treatments for the androgen-independent state of the disease.

Now having identified a cellular link between the two phases of prostate cancer, deVere White and colleagues are hopeful that miR-125b screening will at some point become a standard diagnostic tool and that genetic and chemotherapy treatments can be developed that remove this essential survival mechanism for cancer cells. Before this can happen, the team needs to first find out if a microRNA knockout can be safely accomplished.

We simply dont know yet all that microRNAs do for us, said deVere White. We will use animal models to see if we can reduce or remove one of more of them without interfering with other essential molecular functions.

Another important next step is to identify the full range of microRNAs involved in prostate cancer.

There are believed to be thousands of microRNAs, and we have only identified a handful that is important to prostate cancer, said Xu-Bao Shi, a project scientist with the UC Davis Department of Urology and lead author on the study. We must next identify if others are involved along with their regulating patterns and mechanisms in order to gain a more comprehensive picture of how they contribute to the onset and progression of the disease. Our study definitely opens up a whole new avenue in prostate cancer research.


'/>"/>

Contact: Karen Finney
karen.finney@ucdmc.ucdavis.edu
916-734-9064
University of California - Davis - Health System
Source:Eurekalert

Related medicine news :

1. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
2. ABC TV San Francisco Features Canine Cancer Research Story: Saving Our Dogs, Helping Humans Beat Cancer - Work at Morris Animal Foundation, UC-Davis
3. After Dropping 162 Pounds, Jodi Davis Inspires Other Michigan Women to Get Moving and Lose Weight Through WalkyTalk.com(TM)
4. UC Davis researchers find evidence of mature heart cell potential in embryonic stem cells
5. UC Davis researchers discover novel pathway to increased inflammation in diabetes patients
6. Stanford researchers find culprit in aging muscles that heal poorly
7. UCLA researchers identify markers that may predict diabetes in still-healthy people
8. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
9. Bipolar disorder relapses halved by Melbourne researchers
10. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
11. High and mighty: first common height gene identified by researchers behind obesity gene finding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... MENLO PARK, Calif. , Oct. 11, 2017 /PRNewswire/ ... a national scientific team that developed an innovative way ... and quantity of the delivery of new drugs. ... the 2017 Fall Clinical Dermatology Conference will show how ... Massachusetts General Hospital, Harvard Medical School used a suite ...
(Date:10/10/2017)... 10, 2017  NDS received FDA 510(k) clearance in May 2017 ... display stand specifically designed for endoscopy environments. An innovative secondary monitor ... clinical solution to support the improvement of patient outcomes, procedural efficiency, ... ... ...
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
Breaking Medicine Technology: